Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/05/025338
CTRI/2020/05/025338
Completed
Phase 2

Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms)- An open label single arm prospective clinical trial

Central Council For Research in Ayurvedic Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council For Research in Ayurvedic Sciences
Enrollment
40
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 1, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Asymptomatic, Mild to moderate cases registered in A \& U, Tibia hospital above 18\-60 years of age, with COVID 2019 (Confirmed by RT\-PCR or Rapid Antigen Test) quarantined at identified hospital set up.
  • •2\.Participants who can take medicines orally
  • •3\.Patients willing to provide signed informed consent

Exclusion Criteria

  • •1\.Cases of severe vomiting which would make oral administration of medicine difficult.
  • •2\.Cases of respiratory failure and requiring mechanical ventilation.
  • •3\.Alanine Transaminase (ALT) or Aspartate Transaminase (AST) \> 2 times the upper limit of normal.
  • •4\.Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
  • •5\.Pregnant or lactating women
  • •6\.Any other condition, which as per the investigator would jeopardize the outcome of the trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness
CTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
Completed
Phase 3
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
Not yet recruiting
Phase 2
Study of use of Ayurveda Intervention (Ayush-64) in COVID 19
CTRI/2020/06/026002ational Institute of Ayurveda
Not yet recruiting
Not Applicable
Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiota
CTRI/2020/10/028746AMRIT GODBOLE
Completed
Phase 2
Clinical trial of CIM-Meg19 in COVID-19 patients
CTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80